Socioeconomic and demographic factors impact surgical outcomes in upper extremity soft tissue sarcomas, affecting amputation ...

Despite such guidelines, though, the investigators said there is a lack of evidence-based or widely accepted consensus on ...

A small number of cancer cells with the ability to change their identities and behaviors appear to be a key driver of cancer ...

The FDA has granted orphan drug designation (ODD) to LP-284, a next-generation acylfulvene small molecule, for the treatment ...

LIXTE Biotechnology Holdings, Inc. ('LIXTE” or the 'Company”) (Nasdaq: LIXT), a clinical-stage pharmaceutical company ...

Lantern Pharma Inc. (NASDAQ: LTRN), a clinical-stage biopharmaceutical company using artificial intelligence to transform the ...

Dad Brett Harman, 35, tragically lost his fiancée to cancer only a few years after battling the disease himself - but says it ...

Annamycin consistently demonstrates no evidence of cardiotoxicity across five clinical trials– This next-generation anthracycline demonstrates ...

A sarcoma cancer charity founded by a Coleraine woman has been praised by the Health Minister.

First MIRACLE trial unblinding expected Q1 2026; Global trial now spans nine countries– Investigator-Initiated (IIT) funded pancreatic and ...

Agenus Inc. ( Nasdaq: AGEN ), a leader in immuno-oncology innovation, today announced that France’s National Agency for ...

For months, Tasmanian Aidyn Clements ignored the fatigue she put down to motherhood - until one ordinary evening revealed a ...